Necthreonin D
| Internal ID | b9339787-f6a7-479a-8ae5-c9384e12cf98 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | (2S)-1-[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]-N-[(2S)-1-[[(2S)-1-[[2-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-hydroxy-4-methylpentan-2-yl]amino]-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-2-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C52H93N11O13/c1-17-30(9)40(60-43(69)32(11)54-42(68)31(10)55-44(70)36(23-28(5)6)56-34(13)66)48(74)61-51(14,15)50(76)63-21-19-20-38(63)46(72)58-37(24-29(7)8)45(71)62-52(16,18-2)49(75)53-25-39(67)59-41(33(12)65)47(73)57-35(26-64)22-27(3)4/h27-33,35-38,40-41,64-65H,17-26H2,1-16H3,(H,53,75)(H,54,68)(H,55,70)(H,56,66)(H,57,73)(H,58,72)(H,59,67)(H,60,69)(H,61,74)(H,62,71)/t30-,31-,32-,33+,35-,36-,37-,38-,40-,41-,52-/m0/s1 |
| InChI Key | YPXZPIGWQIPLFY-SBWGTBJRSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C52H93N11O13 |
| Molecular Weight | 1080.40 g/mol |
| Exact Mass | 1079.69543206 g/mol |
| Topological Polar Surface Area (TPSA) | 352.00 Ų |
| XlogP | 2.20 |
| Atomic LogP (AlogP) | -0.72 |
| H-Bond Acceptor | 13 |
| H-Bond Donor | 12 |
| Rotatable Bonds | 31 |
| RefChem:164973 |
| (2S)-1-(2-(((2S,3S)-2-(((2S)-2-(((2S)-2-(((2S)-2-acetamido-4-methylpentanoyl)amino)propanoyl)amino)propanoyl)amino)-3-methylpentanoyl)amino)-2-methylpropanoyl)-N-((2S)-1-(((2S)-1-((2-(((2S,3R)-3-hydroxy-1-(((2S)-1-hydroxy-4-methylpentan-2-yl)amino)-1-oxobutan-2-yl)amino)-2-oxoethyl)amino)-2-methyl-1-oxobutan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide |
| (2S)-1-[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]-N-[(2S)-1-[[(2S)-1-[[2-[[(2S,3R)-3-hydroxy-1-[[(2S)-1-hydroxy-4-methylpentan-2-yl]amino]-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-2-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide |
| (2S)-N-((1S)-1-(((((1S,2R)-2-hydroxy-1-(((2S)-1-hydroxy-4-methylpentan-2-yl)-C-hydroxycarbonimidoyl)propyl)-C-hydroxycarbonimidoyl)methyl)-C-hydroxycarbonimidoyl)-1-methylpropyl)-2-((hydroxy((2S)-1-(2-(((2S,3S)-1-hydroxy-2-(((2S)-1-hydroxy-2-(((2S)-1-hydroxy-2-(((2S)-1-hydroxy-2-((1-hydroxyethylidene)amino)-4-methylpentylidene)amino)propylidene)amino)propylidene)amino)-3-methylpentylidene)amino)-2-methylpropanoyl)pyrrolidin-2-yl)methylidene)amino)-4-methylpentanimidate |
| (2S)-N-[(1S)-1-[({[(1S,2R)-2-hydroxy-1-{[(2S)-1-hydroxy-4-methylpentan-2-yl]-C-hydroxycarbonimidoyl}propyl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]-1-methylpropyl]-2-({hydroxy[(2S)-1-(2-{[(2S,3S)-1-hydroxy-2-{[(2S)-1-hydroxy-2-{[(2S)-1-hydroxy-2-{[(2S)-1-hydroxy-2-[(1-hydroxyethylidene)amino]-4-methylpentylidene]amino}propylidene]amino}propylidene]amino}-3-methylpentylidene]amino}-2-methylpropanoyl)pyrrolidin-2-yl]methylidene}amino)-4-methylpentanimidate |
| CHEBI:215111 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7044 | 70.44% |
| Caco-2 | - | 0.8595 | 85.95% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.6429 | 64.29% |
| Subcellular localzation | Mitochondria | 0.5045 | 50.45% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8553 | 85.53% |
| OATP1B3 inhibitior | + | 0.9214 | 92.14% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 1.0000 | 100.00% |
| BSEP inhibitior | + | 0.9417 | 94.17% |
| P-glycoprotein inhibitior | + | 0.7420 | 74.20% |
| P-glycoprotein substrate | + | 0.8572 | 85.72% |
| CYP3A4 substrate | + | 0.7272 | 72.72% |
| CYP2C9 substrate | - | 0.7982 | 79.82% |
| CYP2D6 substrate | - | 0.8357 | 83.57% |
| CYP3A4 inhibition | - | 0.7980 | 79.80% |
| CYP2C9 inhibition | - | 0.8917 | 89.17% |
| CYP2C19 inhibition | - | 0.8000 | 80.00% |
| CYP2D6 inhibition | - | 0.8901 | 89.01% |
| CYP1A2 inhibition | - | 0.9193 | 91.93% |
| CYP2C8 inhibition | + | 0.5799 | 57.99% |
| CYP inhibitory promiscuity | - | 0.9307 | 93.07% |
| UGT catelyzed | + | 0.9000 | 90.00% |
| Carcinogenicity (binary) | - | 0.7900 | 79.00% |
| Carcinogenicity (trinary) | Non-required | 0.6186 | 61.86% |
| Eye corrosion | - | 0.9845 | 98.45% |
| Eye irritation | - | 0.8975 | 89.75% |
| Skin irritation | - | 0.7882 | 78.82% |
| Skin corrosion | - | 0.9000 | 90.00% |
| Ames mutagenesis | - | 0.6900 | 69.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3821 | 38.21% |
| Micronuclear | + | 0.6500 | 65.00% |
| Hepatotoxicity | + | 0.5834 | 58.34% |
| skin sensitisation | - | 0.8802 | 88.02% |
| Respiratory toxicity | + | 0.7222 | 72.22% |
| Reproductive toxicity | + | 0.7556 | 75.56% |
| Mitochondrial toxicity | + | 0.7250 | 72.50% |
| Nephrotoxicity | + | 0.4668 | 46.68% |
| Acute Oral Toxicity (c) | III | 0.6426 | 64.26% |
| Estrogen receptor binding | + | 0.7382 | 73.82% |
| Androgen receptor binding | + | 0.7136 | 71.36% |
| Thyroid receptor binding | + | 0.5761 | 57.61% |
| Glucocorticoid receptor binding | + | 0.6324 | 63.24% |
| Aromatase binding | + | 0.6955 | 69.55% |
| PPAR gamma | + | 0.7730 | 77.30% |
| Honey bee toxicity | - | 0.7735 | 77.35% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.7200 | 72.00% |
| Fish aquatic toxicity | - | 0.6071 | 60.71% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.94% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.42% | 96.61% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.27% | 89.63% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.94% | 98.94% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.59% | 97.25% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.20% | 98.33% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 98.19% | 95.00% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.59% | 96.09% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.63% | 100.00% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 96.44% | 99.77% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 96.43% | 98.10% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.34% | 93.56% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 96.22% | 94.45% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 96.01% | 100.00% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 95.67% | 98.89% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 95.29% | 97.14% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 94.88% | 95.52% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 94.52% | 96.67% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.51% | 91.19% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 94.36% | 97.50% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.31% | 94.66% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 93.96% | 92.12% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 93.91% | 95.71% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 93.57% | 97.43% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.41% | 100.00% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 92.12% | 97.29% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 92.09% | 86.67% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 91.99% | 95.38% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 91.92% | 96.47% |
| CHEMBL4801 | P29466 | Caspase-1 | 91.55% | 96.85% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 91.51% | 96.67% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 90.80% | 96.31% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.74% | 97.09% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 90.63% | 96.90% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 90.49% | 96.00% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 90.36% | 97.21% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 90.08% | 96.95% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 89.88% | 93.10% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 89.62% | 93.33% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 89.56% | 97.47% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 89.03% | 95.36% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 88.90% | 97.64% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 88.78% | 88.42% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 88.62% | 94.00% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 88.52% | 83.14% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 88.36% | 96.03% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 87.45% | 97.50% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 87.35% | 97.23% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.25% | 94.33% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 87.08% | 90.93% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 86.95% | 82.38% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 86.74% | 96.67% |
| CHEMBL3691 | Q13822 | Autotaxin | 86.57% | 96.39% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 86.54% | 97.64% |
| CHEMBL236 | P41143 | Delta opioid receptor | 85.99% | 99.35% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 85.57% | 92.38% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 85.43% | 81.29% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 84.96% | 98.59% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 84.82% | 92.80% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 84.74% | 100.00% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 84.73% | 98.05% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 84.25% | 96.33% |
| CHEMBL4461 | Q9NTG7 | NAD-dependent deacetylase sirtuin 3 | 84.24% | 94.36% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 84.00% | 90.08% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 83.59% | 93.04% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 83.39% | 95.00% |
| CHEMBL3004 | P33527 | Multidrug resistance-associated protein 1 | 83.37% | 96.37% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 83.20% | 95.83% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 83.09% | 95.17% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 82.75% | 89.33% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 81.87% | 90.24% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 81.85% | 90.71% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 81.67% | 97.29% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 81.57% | 90.65% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 80.97% | 98.57% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 80.62% | 95.89% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 80.32% | 95.50% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 80.11% | 99.17% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139590864 |
| LOTUS | LTS0233876 |
| wikiData | Q105352062 |